NDC 63323-487-01 - XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE)
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-487
- Requested NDC
- 63323-487-01
- Package NDCs from labels
- 63323-487-01, 63323-487-17, 63323-487-07, 63323-487-37, 63323-487-03, 63323-487-31
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2024-01-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE ANHYDROUS - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2021-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
| D-Care 100X | RX PHARMA-PACK, INC. | 2020-01-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-487-01 | XylocaineMPF | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 13 | |
| 63323-487-03 | XylocaineMPF | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 13 | |
| 63323-487-07 | XylocaineMPF | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 13 | |
| 63323-487-17 | XylocaineMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-487-31 | XylocaineMPF | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 13 | |
| 63323-487-37 | XylocaineMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-487 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 13 | Current NDC, Legacy NDC, 6 package rows | 20210831_ba082c2f-64f4-419d-9c88-74f203316e17.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-487-01 | ML - Milliliter | 63323-487 | abacec98-8d14-4aa0-aa91-b6665598d9d4 | 1 | 2020-04-20 |
| 63323-487-03 | ML - Milliliter | 63323-487 | 31057550-cb80-49a9-8868-2ad97e93ffd4 | 1 | 2021-08-05 |
| 63323-487-07 | ML - Milliliter | 63323-487 | 68a4710a-174b-475a-b197-3f4825c0e107 | 1 | 2019-12-10 |
| 63323-487-17 | ML - Milliliter | 63323-487 | c42ff282-3515-499f-92e8-5ecfb162219f | 1 | 2012-07-24 |
| 63323-487-31 | ML - Milliliter | 63323-487 | cad5209d-3130-4dc4-be24-70f0e8b8a586 | 1 | 2012-07-24 |
| 63323-487-37 | ML - Milliliter | 63323-487 | 8363510f-c58b-4562-9d74-c40d7177fc6b | 1 | 2012-07-24 |
| 63323-487-92 | ML - Milliliter | 63323-487 | d35b690d-19f4-45c3-aaca-382312b925bf | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Drs. pharmacy triple antibiotic | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE OINTMENT | OL PHARMA TECH, LLC | bb730976-0045-c0ae-e053-2a95a90af34e | 2025-01-09 | Warnings | M003 |
| Drs. Antibiotic Bacitracin | BACITRACIN | OL PHARMA TECH, LLC | c26493c4-0bc1-5fdc-e053-2995a90a81e6 | 2025-01-09 | Warnings | M003 |
| Drs. Pharmacy Triple Antibiotic Plus | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, LIDOCAINE | OL PHARMA TECH, LLC Drs PHARMACY | d037bfb8-0d8c-4eda-e053-2995a90ae1f2 | 2025-01-09 | Warnings | M003 |
| AM-11 | ARNICA MONTANA, SODIUM CHLORIDE, AND APIS MELLIFERA | DNA Labs, Inc. | c072811b-6259-4b22-b364-50369dc68fb0 | 2025-01-09 | Warnings | 451W47IQ8X |
| Marlido Kit | MARCAINE, LIDOCAINE, POVIDONE IODINE | Asclemed USA, Inc. | e942a88a-7cb1-4c99-b70f-4c48994bb84e | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | 1737761 |
| N-13 | CEANOTHUS AMERICANUS LEAF, URTICA URENS, SODIUM CHLORIDE, LACHESIS MUTA WHOLE, CINCHONA OFFICINALIS BARK, LYCOPODIUM CLAVATUM WHOLE, FERRIC CHLORIDE HEXAHYDRATE, AND SUS SCROFA SPLEEN | DNA Labs, Inc. | 146c5465-bcd9-4057-8975-dc1088b9971b | 2025-01-09 | Warnings | 451W47IQ8X |
| N-10 | SODIUM CHLORIDE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, SEPIA OFFICINALIS JUICE, IODINE, LYCOPODIUM CLAVATUM WHOLE, AND BOS TAURUS PITUITARY GLAND, POSTERIOR | DNA Labs, Inc. | 264d8093-70f3-43a5-bfc4-b719bb3e45e6 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-16 | MGO ENERGIZER | DNA Labs, Inc. | 8292b900-86c1-47ea-81da-b587439c7664 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-21 | CALCIUM FLUORIDE, SILICON DIOXIDE, EUPHRASIA STRICTA, RUTA GRAVEOLENS WHOLE, GELSEMIUM SEMPERVIRENS WHOLE, PHYSOSTIGMA VENENOSUM WHOLE, ANEMONE PULSATILLA, SODIUM CHLORIDE, AND SUS SCROFA EYE | DNA Labs, Inc. | 89967941-c4ee-4598-a66d-8a93d69a4d65 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-14 | FUCUS VESICULOSUS, SODIUM CHLORIDE, LYCOPUS VIRGINICUS, SPONGIA OFFICINALIS SKELETON, ROASTED, POTASSIUM IODIDE, CALCIUM IODIDE, THYROID, UNSPECIFIED, BOS TAURUS ADRENAL GLAND, BOS TAURUS PITUITARY GLAND, POSTERIOR, BOS TAURUS THYMUS, AND SUS SCROFA SPLEEN | DNA Labs, Inc. | 3d64739c-5d61-4e88-8612-d5f6994f1c3c | 2025-01-09 | Warnings | 451W47IQ8X |
| N-24 | METABOLIN | DNA Labs, Inc. | 559fca2b-1093-4bdf-be70-c453f87002c3 | 2025-01-09 | Warnings | 451W47IQ8X |
| T-27 | WATER | DNA Labs, Inc. | f0e9afd7-64a4-4b85-9c5f-4bf07ba4b481 | 2025-01-09 | Warnings | 059QF0KO0R |
| BACTINE MAX | BACTINE MAX WOUND WASH | WellSpring Pharmaceutical Corporation | 39b26c28-93e0-41a9-8018-f73525ebc015 | 2025-01-08 | Warnings | M003 |
| sterile | POVIDONE-IODINE | Asia Dynamics Inc., d/b/a ADI Medical | 0658a0c8-f5ec-b380-e063-6394a90afff5 | 2025-01-08 | Warnings | M003 85H0HZU99M |
| Sterile Water | STERILE WATER FOR INJECTION | Medefil, Inc. | 99e99a50-82d5-aff6-e053-2a95a90a8c56 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| 1% LIDOCAINE HCI | 1% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 999b1c7b-3495-926a-e053-2a95a90ab206 | 2025-01-08 | Warnings, Adverse reactions | 1010033 1010671 |
| BACTERIOSTATIC WATER | BACTERIOSTATIC WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b0ef9b-600a-40dc-e053-2a95a90aa07e | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 8dfb05c0-77e8-2fa1-e053-2a95a90a3d33 | 2025-01-08 | Adverse reactions | 451W47IQ8X |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b1cb12-0b2d-0c0f-e053-2a95a90ac3b6 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| SODIUM CHLORIDE | SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 998a2a47-5c79-2efd-e053-2995a90a8fac | 2025-01-08 | Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.